Akoya Biosciences Inc at JPMorgan Healthcare Conference Transcript
&-
Perfect. Good afternoon, everyone. This is Rachel Vatnsdal with the life science tools and diagnostics team at JPMorgan. I'm joined today with the Akoya Biosciences management team up here. And so if any of you in the room do have questions, please feel free to send them to me directly or you can submit them via portal. With that, I will ask Brian to kick us off with the presentation.
Thank you, Rachel. On behalf of all my colleagues at Akoya, thanks to you and your team at JPMorgan for having us. So again, I'm Brian McKelligon, the CEO of Akoya. Maybe just before I get started, I think Akoya, I think we're both proud and humbled by the journey over the last five or six years. Proud in that we've taken a handful of people and this idea of spatial biology and turned it into a company that's going to deliver just under $100 million this year. But really humbled because we feel like we have some distance to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
